The nonprofit organization presents evidence of strategic thinking and goal setting through sharing their most important strategic goals.
Goal One: Fund >9M in research
with priority to addressing mechanisms of cardiac dysfunction, metabolic changes
in FA, and neuron development
and dysfunction
Goal Type: Grow, expand, scale or increase access to the existing programs and services.
Goal Two: Facilitate an FA treatment pipeline with 6 treatment approaches
& >18 candidates in development or
clinical trials
Goal Type: Grow, expand, scale or increase access to the existing programs and services.
Goal Three: Grow the collaborative
clinical research network to support next generation clinical trials
Goal Type: Grow, expand, scale or increase access to the existing programs and services.